Moerae Matrix
is a biopharmaceutical company, develops targeted therapeutics for fibrotic diseases... Read moreMoerae Matrix
is a biopharmaceutical company, develops targeted therapeutics for fibrotic diseases... Read more
News
Jul 28, 2015
BIOSPACE
Moerae Matrix: <b>Moerae</b> Initiates Lipopolysaccharide (LPS) Challenge Study Of Inhaled MMI-0100 For Pulmonary Disease Following Encouraging Safety And Tolerability Observed In Single Ascending Dose Phase 1 Study
Jul 28, 2015
PR NEWSWIRE
Press Release: Moerae Matrix : Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study
Jul 07, 2015
OINDP NEWS
Moerae Matrix: Moerae Matrix hires Bill Bradford as Chief Medical Officer
Jul 06, 2015
PR NEWSWIRE
Press Release: Moerae Matrix : Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer
Aug 05, 2014
PR NEWSWIRE
Press Release: Moerae Matrix : Moerae Matrix Initiates Phase 1 Clinical Trial of MMI-0100, a First-in-Class Inhibitor of MK2, for Treatment of Idiopathic Pulmonary Fibrosis
Aug 05, 2014
BIOSPACE
Moerae Matrix: <b>Moerae Matrix</b> Initiates Phase 1 Clinical Trial Of MMI-0100, A First-In-Class Inhibitor Of MK2, For Treatment Of Idiopathic Pulmonary Fibrosis
Moerae Matrix Competitors
1
2
3
4
5
6
7
8
9
10